214 related articles for article (PubMed ID: 27876629)
1. Improvement of idiopathic membranous nephropathy diagnosis with ultrasensitive quantitative detection of anti-phospholipase A2 receptor.
Huang B; Wang L; Cao YN; Zhang Y; Zhang J; Xiao H; Zhang Q; Wang W; Sun Z; Chen Y; Hu Z; Sheng H
J Allergy Clin Immunol; 2017 Jun; 139(6):1988-1990.e2. PubMed ID: 27876629
[No Abstract] [Full Text] [Related]
2. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.
Zhang Q; Huang B; Liu X; Liu B; Zhang Y; Zhang Z; Hua J; Fan Y; Hu L; Meng M; Wu M; Wang L; Hu Z; Sun Z
Sci Rep; 2017 Sep; 7(1):12049. PubMed ID: 28935926
[TBL] [Abstract][Full Text] [Related]
3. Anti-PLA2R antibody in a secondary cause of membranous nephropathy.
Hari Krishna Reddy M; Kumar AC; Sangeetha B; Ram R; Siva Kumar V
Nephrology (Carlton); 2018 Jan; 23(1):94-95. PubMed ID: 29250915
[No Abstract] [Full Text] [Related]
4. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
[TBL] [Abstract][Full Text] [Related]
5. [Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?].
Netti GS; Ranieri E
G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030016
[TBL] [Abstract][Full Text] [Related]
6. Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.
van de Logt AE; Dahan K; Rousseau A; van der Molen R; Debiec H; Ronco P; Wetzels J
Kidney Int; 2018 Apr; 93(4):1016-1017. PubMed ID: 29571438
[No Abstract] [Full Text] [Related]
7. The accuracy of the anti-phospholipase A2 receptor antibody in the diagnosis of idiopathic membranous nephropathy: a comparison of different cutoff values as measured by the ELISA method.
Dou Y; Zhang L; Liu D; Wang C; Quan S; Ma S; Xiao J; Cheng G; Liu Z; Zhao Z
Int Urol Nephrol; 2016 Jun; 48(6):845-9. PubMed ID: 27017339
[TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA
Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329
[TBL] [Abstract][Full Text] [Related]
9. Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy.
Cravedi P; Ruggenenti P; Remuzzi G
J Am Soc Nephrol; 2011 Aug; 22(8):1400-2. PubMed ID: 21784892
[No Abstract] [Full Text] [Related]
10. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
11. Quantity Versus Quality of Anti-Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate Continues.
Beck LH
Am J Kidney Dis; 2024 May; 83(5):566-568. PubMed ID: 38260930
[No Abstract] [Full Text] [Related]
12. Nephrotic syndrome: A new specific test for idiopathic membranous nephropathy.
Debiec H; Ronco P
Nat Rev Nephrol; 2011 Aug; 7(9):496-8. PubMed ID: 21826078
[No Abstract] [Full Text] [Related]
13. [The relationship between anti-phospholipase A2 receptor antibody and idiopathic membranous nephropathy].
Lin W; Li H; Li X; Qin Y; Su Y; Yu Y; Guan Y; Duan L; Li Y; Wen Y; Li X
Zhonghua Nei Ke Za Zhi; 2015 Sep; 54(9):783-8. PubMed ID: 26674797
[TBL] [Abstract][Full Text] [Related]
14. Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?
Hofstra JM; Wetzels JF
Neth J Med; 2012 Apr; 70(3):109-13. PubMed ID: 22516574
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V
Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981
[TBL] [Abstract][Full Text] [Related]
16. Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody.
Dahan K; Johannet C; Esteve E; Plaisier E; Debiec H; Ronco P
Kidney Int; 2019 Jan; 95(1):233-234. PubMed ID: 30606419
[No Abstract] [Full Text] [Related]
17. Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy.
Seitz-Polski B; Dolla G; Payré C; Tomas NM; Lochouarn M; Jeammet L; Mariat C; Krummel T; Burtey S; Courivaud C; Schlumberger W; Zorzi K; Benzaken S; Bernard G; Esnault VL; Lambeau G
Biochimie; 2015 Nov; 118():104-15. PubMed ID: 26296473
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1.
Schlumberger W; Hornig N; Lange S; Probst C; Komorowski L; Fechner K; Dähnrich C; Stöcker W
Autoimmun Rev; 2014 Feb; 13(2):108-13. PubMed ID: 24075959
[TBL] [Abstract][Full Text] [Related]
19. Management of Membranous Nephropathy in the PLA
Bomback AS
Clin J Am Soc Nephrol; 2018 May; 13(5):784-786. PubMed ID: 29378770
[No Abstract] [Full Text] [Related]
20. Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study.
Timmermans SA; Damoiseaux JG; Heerings-Rewinkel PT; Ayalon R; Beck LH; Schlumberger W; Salant DJ; van Paassen P; Tervaert JW;
Am J Clin Pathol; 2014 Jul; 142(1):29-34. PubMed ID: 24926082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
